LDLR rs121908485: Understanding This Genetic Variant

What each genotype means

What is the rs121908485 Variant?

The rs121908485 variant is a single nucleotide polymorphism (SNP) located within the LDLR gene on chromosome 19. In genetics, a SNP represents a variation at a single position in the DNA sequence. The LDLR gene is responsible for producing the low-density lipoprotein receptor, a protein that plays a critical role in cholesterol metabolism. This receptor sits on the surface of cells, particularly in the liver, and acts like a vacuum cleaner to remove LDL cholesterol—often called 'bad' cholesterol—from the bloodstream. When the gene contains a variant that alters the structure or function of this receptor, the body's ability to clear LDL cholesterol from the blood can be impaired. This can lead to higher circulating levels of cholesterol, which is a primary focus of research into cardiovascular health and lipid metabolism.

The Role of the LDLR Gene

The LDLR gene is essential for maintaining healthy cholesterol levels. The protein it encodes, the LDL receptor, binds to LDL particles in the blood and facilitates their uptake into cells through a process called receptor-mediated endocytosis. Once inside the cell, the cholesterol is processed and used for various biological functions, such as building cell membranes or producing hormones. When the LDLR gene is functioning correctly, it helps keep blood cholesterol levels within a normal range. However, pathogenic variants in this gene can disrupt this process, leading to familial hypercholesterolemia (FH). FH is an inherited condition that causes very high levels of LDL cholesterol from birth. If left unmanaged, these high levels can lead to the buildup of plaque in the arteries, significantly increasing the risk of heart attacks and other cardiovascular issues at a younger age than the general population.

Research and Evidence Strength

The association between specific LDLR variants and familial hypercholesterolemia is a major area of clinical research. While many variants in the LDLR gene are clearly pathogenic, the evidence strength for any single variant can vary based on clinical data, functional studies, and segregation analysis within families. For rs121908485, the evidence is currently categorized as limited. In clinical genetics, 'limited' evidence means that while the variant has been identified in individuals with relevant traits, there is not yet enough robust, peer-reviewed data to definitively classify its impact on protein function or disease risk. Researchers often use standardized guidelines, such as those from the ClinGen Familial Hypercholesterolemia Expert Panel, to evaluate whether a variant is likely to cause disease. Because the field of genomics is constantly evolving, ongoing research and the accumulation of more case-level data are necessary to better understand the clinical significance of this specific variant.

Population Frequency

The rs121908485 variant is considered rare in the general population. According to large-scale genomic databases like gnomAD, the frequency of this variant is reported to be less than 0.0001. This rarity is common for variants associated with monogenic conditions like familial hypercholesterolemia, where the disease-causing alleles are not widely distributed across the global population. Because the variant is so infrequent, it is difficult to conduct large-scale population studies to determine its exact prevalence across different ancestral groups. Most of the information regarding such rare variants comes from clinical testing of individuals who have already been diagnosed with or are being screened for high cholesterol. As more people participate in genomic research, our understanding of how rare variants like rs121908485 are distributed across diverse populations will continue to improve.

What You Can Do With This Information

If you have received information about your genotype regarding rs121908485, it is important to approach it with a clear understanding of its limitations. Genetic information is only one piece of the puzzle when it comes to your health. Because the evidence for this variant is limited, it should not be used as a standalone diagnostic tool. If you are concerned about your cholesterol levels or your family history of heart disease, the most effective step is to consult with a healthcare provider or a genetic counselor. They can interpret your results in the context of your overall health, including your diet, lifestyle, and other clinical markers. Never make changes to your medical care or medication regimen based on genetic reports without first discussing them with your doctor. A clinical professional can help you determine if further testing or specialized cardiovascular screening is appropriate for your specific situation.

Frequently asked questions

Sources & further reading

Related variants in LDLR